CAMBRIDGE MEDICAL INNOVATION LTD

What CAMBRIDGE MEDICAL INNOVATION LTD does

Cambridge Medical Innovation Ltd operates under the DigiVis brand, developing SaaS web applications for clinical self-testing and triage in ophthalmic care. Founded in 2020 and headquartered in Great Chesterford, England, the company builds cloud-hosted software tools designed for use within NHS and healthcare provider pathways. Its core products are DigiVis DVA, a self-administered distance visual acuity test replicating standard logMAR charts across two internet-connected devices; eye+dot, a structured triage questionnaire for evaluating and prioritising patients with eye conditions in urgent and primary care; and the DigiVis Portal, a customer administration platform with API integration to electronic patient record (EPR) systems. All products are registered or compliant with relevant NHS standards, including UKCA Class 1 medical device registration for DigiVis DVA, DTAC, and DCB0129.

The company's revenue model combines SaaS subscriptions with pay-as-you-go pricing, offering volume discounts to healthcare provider organisations. Distribution is exclusively direct-to-provider, with applications accessible only through activation links issued by registered healthcare professionals. Its primary customer segments are NHS and private ophthalmology services, urgent and emergency eye care, community optometry, and school health services. The go-to-market motion is enterprise field sales targeting NHS Trusts and healthcare providers, supported by clinical validation evidence including peer-reviewed publications in journals such as Eye and BMJ Open Ophthalmology, and an NIHR-funded 30-month ReVise study across three large NHS eye departments.

Technically, the platform is hosted on AWS with UK-based data centres and CloudFront CDN delivery, with infrastructure partners including AWS, Xero for billing, and ClickSend for SMS notifications. The company was founded by Dr. Louise Allen, a Consultant Paediatric Ophthalmologist at Cambridge University Hospitals, and Dr. Nick Toff, formerly of the NHS Healthcare Safety Investigation Branch. No institutional funding rounds or revenue figures have been disclosed publicly.

Name

CAMBRIDGE MEDICAL INNOVATION LTD

Legal name

Cambridge Medical Innovation Ltd

Website

https://digivis.uk

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Cambridge Medical Innovation Ltd (DigiVis) builds SaaS web applications for clinical self-testing and triage in ophthalmology, serving NHS hospitals, urgent eye care services, and community optometry with UKCA-registered, clinically validated tools.

Ownership category

akta.pro rank

Product category

Ophthalmology Clinical Software

NAICS

Medical and Diagnostic Laboratories (62151), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ophthalmology & Vision Telemedicine Platforms (HLALAGAL)

akta.pro secondary industries

Comprehensive Eye Exams & Vision Care (HLAKAKAA), Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC), Optometry Clinics (Primary Eye Care) (HLAKAKAB)

Keywords

• Clinical self-testing software
• Ophthalmology web applications
• Visual acuity testing
• Patient triage software
• Medical SaaS platform

Headquarters

HQ city

Great Chesterford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. SaaS Subscriptions: Subscription-based access to DigiVis applications with all products including Customer Portal. Offers significant volume discounts for higher usage.
2. Pay-as-you-go: Usage-based pricing option where customers pay per test ordered. Subject to minimum charge. Suitable for organisations with variable testing needs.
3. API Integration Services: API integration with customer systems and EPR (Electronic Patient Records) enabling order creation and result viewing directly from customer systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Cambridge Medical Innovation Ltd develops and delivers SaaS web applications for clinical self-testing and triage in ophthalmic and hearing care pathways. Under the DigiVis brand, the company offers DigiVis DVA for self-administered distance visual acuity testing, eye+dot as a structured triage questionnaire for urgent eye care, and the DigiVis Portal for customer account administration, API integration, and reporting.

Product overview

Cambridge Medical Innovation Ltd operates under the DigiVis brand, offering a platform of complementary self-administered web applications for vision and hearing evaluation. The product portfolio includes DigiVis DVA (distance visual acuity self-testing), eye+dot (eye condition triage questionnaire), and DigiVis Portal (customer administration). All applications are delivered using a software-as-a-service (SaaS) model, designed for clinical use through healthcare provider organisations. The products are clinically proven with full regulatory approval and are targeted at NHS ophthalmology services, urgent care settings, and remote consultation use cases.

Differentiator

Problem solved

Functional benefit

Brands

• DigiVis DVA: A self-administered test of distance visual acuity (DVA) web application, registered as a Class 1 medical device. Includes Standard, Kiosk, and Podium modes of use.
• eye+dot
• DigiVis Portal

Products and services

• DigiVis DVA A self-administered web application that replicates standard logMAR charts for testing distance visual acuity at home, in the community, and in clinical, regulatory, or commercial settings. It uses two internet-connected devices, one as a distant letter chart display and the other for user input, and is registered as a UKCA Class 1 medical device. Sold to healthcare provider organisations for use with their registered professionals and patients.
• eye+dot A structured interactive online questionnaire designed by NHS ophthalmologists to help primary and secondary urgent eye care services evaluate and prioritise patients with eye conditions. Provides rapid triage and suggested disposition or urgency recommendations to support patient signposting.
• DigiVis Portal A customer portal included with all DigiVis products that allows healthcare provider organisations to configure accounts, manage users, order tests, send email/SMS invitations, view results, generate reports, and integrate with customer systems and EPR via API.

Quantifiable outcome

• 91.2% of DVA tests informative and contributed to clinical decision making
• +5 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and infrastructure.

• NIHR (National Institute for Health and Care Research)coreStrategic or Co-development PartnerNIHR-funded ReVise study (NIHR204635) - a 30-month study in three large NHS eye departments co-designing a scalable implementation model for remote consultation with vision self-testing. Estimated to involve over 22,000 patients with diverse demographics.
• NHScoreStrategic or Co-development PartnerDigiVis applications were designed to improve NHS ophthalmology services. Multiple NHS hospitals are involved in clinical validation studies and real-world implementation. NHS logo displayed on website as recognition of partnership.
• Amazon Web Services (AWS)infrastructureTechnology or IntegrationAWS used for data storage of test application results and email communications. Data hosted in UK-based AWS facilities.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Peek Vision: UK-based provider of smartphone-based eye screening and vision testing tools used by NGOs and health systems. Comparable mission of enabling self-administered vision testing at scale, particularly in community and school settings.
• IbisVision: UK-based telehealth platform providing online eye tests and remote vision assessments for optometry practices. Most directly comparable peer given overlapping UK market, ophthalmology focus, and web/SaaS delivery model.
• PlenOptika (EyeNetra): Developer of autorefraction and vision screening devices including QuickSee, sold to optometry and global health markets. Comparable in delivering objective, device-enabled vision assessment outside traditional clinics.

Regional players

• Smart Vision Labs: US-based telehealth vision screening provider offering autonomous refraction and remote ophthalmologist review. Similar self-service vision testing value proposition but primarily operating in the US market.

Broad incumbents

• Topcon Healthcare: Major ophthalmic device and healthcare-IT vendor selling diagnostic imaging, refraction, and screening equipment. Adjacent incumbent with ability to bundle self-testing into broader eye-care enterprise contracts.
• Good-Lite: Established US-based supplier of standardized visual acuity charts and vision testing equipment used globally in optometry and ophthalmology. Comparable in providing the standardized visual acuity testing infrastructure that DigiVis digitally replicates.

Emerging players

• NovaSight: Israel-based pediatric vision care company offering eye-tracking based diagnostics and digital treatment. Comparable in targeting pediatric ophthalmology and self-administered digital vision assessment.
• Remidio Innovative Solutions: India-based developer of smartphone-based ophthalmic screening and AI-assisted diagnostic tools. Comparable in deploying portable, low-cost ophthalmic assessment technology to expand access.
• Forus Health (3nethra): India-based manufacturer of portable ophthalmic screening devices used for large-scale community vision programs. Comparable in enabling non-clinician-administered eye screening at population scale.
• Tilak Healthcare: Developer of clinically-validated digital therapeutics and vision monitoring apps prescribed by ophthalmologists. Comparable in delivering clinically-validated software-based ophthalmology products for patient self-monitoring.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAMBRIDGE MEDICAL INNOVATION LTD